Your leading voice in digital health news
Twitter X Logo

Volpara software selected for NHS breast screening project

21 March 2018
Pulse+IT

ASX-listed New Zealand company Volpara Health Technologies has been chosen to provide its VolparaDensity software to a research project being run by the NHS's breast screening program (NHSBSP) in England.

The project is the second stage of the Predicting Risk of Cancer at Screening (PROCAS) study, which aims to improve breast cancer risk prediction for women attending routine breast screening.

Subscribe to read more

Pulse+IT website access

Keep your finger on the pulse with full access to all articles published on pulseit.news
Instant access
All articles
Cancel anytime

Your leading voice in digital health news

Twitter X

Copyright © 2024 Pulse+IT Communications Pty Ltd. No content published on this website can be reproduced by any person for any reason without the prior written permission of the publisher. If your organisation is featured in a Pulse+IT article you can purchase the permission to reproduce the article here.
Website Design by Get Leads AU.

Your leading voice in digital health news 

Keep your finger on the pulse with full access to all articles published on 
pulseit.news
Subscribe from only $39
magnifiercrossmenuchevron-down